Delay in hospital presentation is the main reason large vessel occlusion stroke patients do not receive intravenous thrombolysi.
emergency care
large vessel occlusion stroke
stroke
thrombolysis
Journal
Journal of the American College of Emergency Physicians open
ISSN: 2688-1152
Titre abrégé: J Am Coll Emerg Physicians Open
Pays: United States
ID NLM: 101764779
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
received:
29
06
2023
revised:
12
09
2023
accepted:
18
09
2023
medline:
16
10
2023
pubmed:
16
10
2023
entrez:
16
10
2023
Statut:
epublish
Résumé
Intravenous thrombolysis (IVT) and endovascular therapy (EVT) are the mainstays of treatment for large vessel occlusion stroke (LVOS). Prior studies have examined why patients have not received IVT, the most cited reasons being last-known-well (LKW) to hospital arrival of >4.5 hours and minor/resolving stroke symptoms. Given that LVOS patients typically present moderate-to-severe neurologic deficits, these patients should be easier to identify and treat than patients with minor strokes. This investigation explores why IVT was not administered to a cohort of LVOS patients who underwent EVT. This is an analysis of the Optimizing the Use of Prehospital Stroke Systems of Care (OPUS-REACH) registry, which contains patients from 9 endovascular centers who underwent EVT between 2015 and 2020. The exposure of interest was the receipt of intravenous thrombolysis. Descriptive summary statistics are presented as means and SDs for continuous variables and as frequencies with percentages for categorical variables. Two-sample Two thousand forty-three patients were included and 60% did not receive IVT. The most common reason for withholding IVT was LKW to arrival of >4.5 (57.2%). The second most common contraindication was oral anticoagulation (15.5%). On multivariable analysis, 2 factors were associated with not receiving IVT: increasing age (odds ratio [OR] 0.86; 95% confidence interval [CI] 0.78-0.93) and increasing time from LKW-to hospital arrival (OR 0.45 95% CI 0.46-0.49). Like prior studies, the most frequent reason for exclusion from IVT was a LKW to hospital presentation of >4.5 hours; the second reason was anticoagulation. Efforts must be made to increase awareness of the time-sensitive nature of IVT and evaluate the safety of IVT in patients on oral anticoagulants.
Identifiants
pubmed: 37840864
doi: 10.1002/emp2.13048
pii: EMP213048
pmc: PMC10568043
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e13048Informations de copyright
© 2023 The Authors. Journal of the American College of Emergency Physicians Open published by Wiley Periodicals LLC on behalf of American College of Emergency Physicians.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.
Références
N Engl J Med. 2015 Jun 11;372(24):2285-95
pubmed: 25882376
N Engl J Med. 2018 Feb 22;378(8):708-718
pubmed: 29364767
Stroke. 2022 Jun;53(6):1828-1836
pubmed: 35240861
Neurology. 2021 Nov 30;97(22):e2173-e2184
pubmed: 34635558
Australas Med J. 2013 Mar 31;6(3):152-67
pubmed: 23589739
N Engl J Med. 2015 Jan 1;372(1):11-20
pubmed: 25517348
N Engl J Med. 2015 Mar 12;372(11):1019-30
pubmed: 25671798
N Engl J Med. 2015 Mar 12;372(11):1009-18
pubmed: 25671797
Stroke. 2020 Aug;51(8):2322-2331
pubmed: 32611284
Stroke. 2020 Feb;51(2):533-541
pubmed: 31884908
N Engl J Med. 2018 Jan 4;378(1):11-21
pubmed: 29129157
Stroke. 2018 Mar;49(3):e46-e110
pubmed: 29367334
Lancet. 2022 Jul 9;400(10346):104-115
pubmed: 35810756
Stroke. 2022 Dec;53(12):3557-3563
pubmed: 36252105
Emerg Med J. 2017 Apr;34(4):219-226
pubmed: 27797870
Stroke. 2018 Oct;49(10):2383-2390
pubmed: 30355117
BMC Neurol. 2022 Apr 7;22(1):132
pubmed: 35392840
JAMA. 2022 Feb 22;327(8):760-771
pubmed: 35143601
N Engl J Med. 2015 Jun 11;372(24):2296-306
pubmed: 25882510
Acta Neurol Scand. 2022 Jul;146(1):61-69
pubmed: 35445395
JAMA Neurol. 2022 Aug 1;79(8):768-776
pubmed: 35696198
Int J Stroke. 2023 Feb;18(2):237-241
pubmed: 35262424
Lancet. 2019 Jul 13;394(10193):139-147
pubmed: 31128925